Market Place
Sourcing Support
Termination of Proposed Acquisition of Mayne Pharma
11 Dec 2025 //
BUSINESSWIRE
Australian government blocks Cosette`s Mayne Pharma buy
21 Nov 2025 //
FIERCE PHARMA
Mayne Pharma Shares Fall as Cosette Bid Faces Australian Review
31 Oct 2025 //
REUTERS
Court Blocks Cosette`s $438M Mayne Deal Drop; Shares Surge
15 Oct 2025 //
REUTERS
Mayne Pharma drops 30% as Cosette considers canceling $432M deal
21 May 2025 //
REUTERS
Sol-Gel & Mayne Pharma Purchase Epsolay & Twyneo in U.S.
17 Apr 2025 //
GLOBENEWSWIRE
Cosette snaps up Mayne Pharma for $430M
22 Feb 2025 //
FIERCE PHARMA
Australia`s Mayne Pharma sues Sun Pharma over patent infringement
24 Jul 2024 //
REUTERS
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
29 Dec 2023 //
GLOBENEWSWIRE
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
03 Jan 2023 //
BUSINESSWIRE
TherapeuticsMD to slash its entire workforce of 212 people
10 Dec 2022 //
FIERCEPHARMA
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne
05 Dec 2022 //
BUSINESSWIRE
Mayne Pharma Announced As Recipient Of $4.8M Federal Government Grant
09 May 2022 //
MAYNEPHARMA
Alembic Pharma bags FDA approval for Doxycycline Hyclate delayed-release tablets
04 Jan 2022 //
EXPRESS PHARMA
Metrics Contract Services Adds New Equipment
15 Oct 2021 //
CONTRACTPHARMA
Metrics Contract Services Signs Development & Manufacturing Agreement with ESSA
08 Oct 2021 //
CONTRACTPHARMA
New Efficacy Data Reinforces NEXTSTELLIS® Benefits Across Patient Populations
30 Apr 2021 //
PRNEWSWIRE
Mayne Pharma and Mithra Announce FDA Approval of New Oral Contraceptive Estelle®
16 Apr 2021 //
PRESS RELEASE
U.S. FDA Approves NEXTSTELLIS®, New Oral Contraceptive
16 Apr 2021 //
PRNEWSWIRE
Metrics Names Stephanie Emory Associate Director of Pharma Development
15 Apr 2021 //
NEUROOTHERS
New Data Show NEXTSTELLIS Has Selective Impact On Endocrine Markers
08 Mar 2021 //
PRNEWSWIRE
Metrics Contract Services to Expand Greenville Manufacturing Facility
22 Sep 2020 //
PHARMATECH
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
28 Jul 2020 //
PRNASIA
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
27 Jul 2020 //
PRNEWSWIRE
Mayne Pharma Launches Chlorzoxazone Tablet in the United States
27 Jul 2020 //
PRNASIA
Mayne Pharma Announces FDA Filing Acceptance of NDA for E4/DRSP in the US
24 Jun 2020 //
PRNEWSWIRE
Mayne Pharma Announces FDA Filing Acceptance of New Drug Application for E4/DRSP
23 Jun 2020 //
PRNASIA
Australian firm Mayne Pharma launches migraine drug in US
25 May 2020 //
BIOSPECTRUMASIA
Mayne Pharma launches BAC 300 capsules in the United States
22 May 2020 //
PRNEWSWIRE
Mayne Pharma launches BAC 300 capsules in the United States
21 May 2020 //
PRNASIA
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
16 Apr 2020 //
PR NEWSWIRE
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
15 Apr 2020 //
PR NEWSWIRE
Metrics Completes Japanese Regulatory Inspection
19 Nov 2019 //
CONTRACT PHARMA
Mayne, Mithra bring novel oral contraception in the US
02 Oct 2019 //
PRNASIA
Setback For Dr. Reddy’s As U.S. FDA Hands Out Complete Response Letter
13 Aug 2019 //
BLOOMBERGQUINT
Mayne Pharma opens $80m facility, expands CDMO offering
20 Apr 2018 //
IN PHARMATECHNOLOGY
Mayne Pharma debuts $80M solid dose plant in North Carolina
18 Apr 2018 //
FIERCE PHARMA
Mayne pharma launches generic version of Monodox in Australia
19 Mar 2018 //
BIOSPECTRUM
Why the Mayne Pharma Group Ltd share price is rising today
14 Dec 2017 //
FOOL
Impax Searches for a New CEO
21 Dec 2016 //
THE STREET
Price Fixing Lawsuit Slapped Against Aurobindo, Mylan, Others in US
17 Dec 2016 //
FINANCIAL EXPRESS
States Sue Generic-Drug Companies Over Price-Fixing Allegations
16 Dec 2016 //
WALL STREET JOURNAL
DOJ`s price-fixing investigation could lead to sizable liabilities, analyst says
10 Nov 2016 //
FIERCE PHARMA
Mayne Pharma Pays $50 Million to GlaxoSmithKline for Portfolio Of Dermatology
18 Aug 2016 //
BIOSPACE
Mayne Pharma Commits $80 Million to North Carolina Expansion
04 Aug 2016 //
BIOSOACE
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds
28 Jun 2016 //
FIERCE PHARMA
England-Based Premier Research to Create 260 New Jobs in North Carolina
02 Dec 2015 //
BIOSPACE
Expanding Patheon Begins Hiring Hundreds at Eastern North Carolina Plant
28 Sep 2015 //
BIOSPACE
Mayne kicks off work on new $65M North Carolina plant
24 Sep 2015 //
FIERCE PHARMA MANUFACTURING
Mayne Pharma`s $65 Million Expansion Will Create 110 New Jobs in North Carolina
28 Aug 2015 //
BIOSPACE
